Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-22 11:30 am Sale | 2025-08-20 | 13D | Enzo Biochem, Inc. ENZB | Radoff Bradley Louis | 0 0.000% | -4,820,882 (Position Closed) | Filing History |
| 2025-07-01 5:55 pm Purchase | 2025-06-24 | 13G | Enzo Biochem, Inc. ENZB | Beryl Capital Management LLC | 5,069,789 9.700% | 5,069,789 (New Position) | Filing History |
| 2025-06-30 4:15 pm Purchase | 2025-06-23 | 13D | Enzo Biochem, Inc. ENZB | Battery Ventures XIV, L.P. | 11,575,824 21.800% | 11,575,824 (New Position) | Filing History |
| 2025-06-25 6:00 pm Unchanged | 2025-06-23 | 13D | Enzo Biochem, Inc. ENZB | HARBERT DISCOVERY FUND LP | 5,175,913 9.870% | 0 (Unchanged) | Filing History |
| 2025-06-25 4:33 pm Purchase | 2025-06-23 | 13D | Enzo Biochem, Inc. ENZB | Radoff Bradley Louis | 4,820,882 9.200% | 215,750 (+4.68%) | Filing History |
| 2024-02-14 10:23 am Sale | 2023-12-31 | 13G | Enzo Biochem, Inc. ENZB | 1 Main Capital Management, LLC | 2,500,000 4.950% | -374,125 (-13.02%) | Filing History |
| 2024-02-13 09:35 am Sale | 2023-12-29 | 13G | Enzo Biochem, Inc. ENZB | Renaissance Technologies LLC | 2,479,195 4.910% | -334,769 (-11.90%) | Filing History |
| 2023-09-11 5:14 pm Purchase | 2023-09-01 | 13G | Enzo Biochem, Inc. ENZB | 1 Main Capital Management, LLC | 2,874,125 5.800% | 2,874,125 (New Position) | Filing History |
| 2023-07-24 4:20 pm Sale | 2023-07-24 | 13D | Enzo Biochem, Inc. ENZB | LABCORP HOLDINGS INC. LH | 0 0.000% | -4,862,730 (Position Closed) | Filing History |
| 2023-05-10 5:19 pm Purchase | 2023-03-16 | 13D | Enzo Biochem, Inc. ENZB | Radoff Bradley Louis | 4,605,132 9.300% | 307,032 (+7.14%) | Filing History |
| 2023-03-27 4:32 pm Purchase | 2023-03-16 | 13D | Enzo Biochem, Inc. ENZB | LABCORP HOLDINGS INC. LH | 4,862,730 9.800% | 4,862,730 (New Position) | Filing History |
| 2023-02-13 10:10 am Sale | 2022-12-30 | 13G | Enzo Biochem, Inc. ENZB | Renaissance Technologies LLC | 2,813,964 5.780% | -280,800 (-9.07%) | Filing History |
| 2023-01-23 1:23 pm Purchase | 2022-11-23 | 13D | Enzo Biochem, Inc. ENZB | James G. Wolf | 4,942,400 10.140% | 773,900 (+18.57%) | Filing History |
| 2022-11-23 11:33 am Purchase | 2022-11-23 | 13D | Enzo Biochem, Inc. ENZB | James G. Wolf | 4,168,500 8.560% | 54,000 (+1.31%) | Filing History |
| 2022-10-26 1:07 pm Purchase | 2022-10-18 | 13D | Enzo Biochem, Inc. ENZB | James G. Wolf | 4,114,500 8.450% | 852,000 (+26.11%) | Filing History |
| 2022-03-24 5:50 pm Sale | 2022-03-21 | 13D | Enzo Biochem, Inc. ENZB | Roumell Asset Management LLC | 2,426,771 4.980% | -460,000 (-15.93%) | Filing History |
| 2022-02-14 10:49 am Sale | 2021-12-31 | 13G | Enzo Biochem, Inc. ENZB | Renaissance Technologies LLC | 3,094,764 6.380% | -461,459 (-12.98%) | Filing History |
| 2022-02-10 08:11 am Sale | 2021-12-31 | 13G | Enzo Biochem, Inc. ENZB | The Vanguard Group | 1,783,048 3.680% | -614,750 (-25.64%) | Filing History |
| 2022-01-18 10:56 am Sale | 2021-12-31 | 13G | Enzo Biochem, Inc. ENZB | Evermore Global Advisors LLC | 0 0.000% | -2,605,607 (Position Closed) | Filing History |
| 2022-01-04 11:10 am Unchanged | 2022-01-03 | 13D | Enzo Biochem, Inc. ENZB | Radoff Bradley Louis | 4,298,100 8.900% | 0 (Unchanged) | Filing History |